ImageneBio Inc
42 hedge funds and large institutions have $93.2M invested in ImageneBio Inc in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 8 closing their positions.
157% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 7
1.69% less ownership
Funds ownership: 74.08% → 72.38% (-1.7%)
9% less funds holding
Funds holding: 46 → 42 (-4)
21% less capital invested
Capital invested by funds: $119M → $93.2M (-$25.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$3.16M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
+$1.34M |
| 4 |
BlackRock
New York
|
+$1.03M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$647K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.01M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$1.28M |
| 3 |
Millennium Management
New York
|
-$1.04M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$181K |
| 5 |
Morgan Stanley
New York
|
-$114K |
IMA Hedge Fund Activity: Q3 2022 in Review
42 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2022, worth a combined $93.2M — down 21% from $119M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IMA and 5 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 18 added.
The largest buyer was Point72 Asset Management, adding an estimated $3.16M. The largest seller was Fidelity Investments, cutting an estimated $9.01M.
- 42 institutional investors held ImageneBio Inc (IMA) as of Q3 2022, down from 46 in Q2 2022.
- Funds reported $93.2M of ImageneBio Inc stock for Q3 2022, down 21% quarter-over-quarter.
- 5 funds opened new ImageneBio Inc positions in Q3 2022 and 8 closed out, a net change of -3 holders.
- The largest ImageneBio Inc buyer in Q3 2022 was Point72 Asset Management, an estimated $3.16M added.
- The largest ImageneBio Inc seller in Q3 2022 was Fidelity Investments, an estimated $9.01M sold.
Based on aggregated 13F filings for Q3 2022.